Upcoming events

Latest real-world data on new generation TAVI devices

Session comprising selected EuroPCR 2015 abstract submissions

Presentations available when logged in:

  • First report from the RESPOND study: post-market evaluation of a fully repositionable and retrievable aortic valve in 250 patients treated in routi...
  • 6-month performance of a self-expanding valve in a study of best implantation practices: the ADVANCE II study
  • The DISCOVER registry: early outcomes of a fully repositionable and retrievable transcatheter aortic valve in a real-world population
  • The Italian DFM registry: real-world results of a next generation fully repositionable TAVI device
  • 1-year outcomes of the multicentre clinical trial on the third-generation balloon-expandable transcatheter heart valve in high-risk elderly patient...
  • Primary endpoint results of the REPRISE NG DS first human use study: percutaneous aortic valve implantation with the next generation of a fully rep...